Chemoinformaics analysis of 3,4-dihydroxy-5-methoxybenzoic acid
Molecular Weight | 184.147 | nRot | 2 |
Heavy Atom Molecular Weight | 176.083 | nRig | 7 |
Exact Molecular Weight | 184.037 | nRing | 1 |
Solubility: LogS | -1.404 | nHRing | 0 |
Solubility: LogP | 0.916 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 22.7043 |
nHD | 3 | BPOL | 10.6297 |
QED | 0.592 |
Synth | 1.919 |
Natural Product Likeliness | 1.095 |
NR-PPAR-gamma | 0.166 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.004 |
HIA | 0.031 |
CACO-2 | -5.503 |
MDCK | 0.00000739 |
BBB | 0.269 |
PPB | 0.559021 |
VDSS | 0.476 |
FU | 0.380244 |
CYP1A2-inh | 0.027 |
CYP1A2-sub | 0.483 |
CYP2c19-inh | 0.025 |
CYP2c19-sub | 0.048 |
CYP2c9-inh | 0.076 |
CYP2c9-sub | 0.088 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.129 |
CYP3a4-inh | 0.034 |
CYP3a4-sub | 0.038 |
CL | 8.697 |
T12 | 0.95 |
hERG | 0.026 |
Ames | 0.016 |
ROA | 0.023 |
SkinSen | 0.451 |
Carcinogencity | 0.029 |
EI | 0.965 |
Respiratory | 0.077 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.876427 |